Cellcentric Raises £90M to Prevent Cancer Deaths


credit: USACE on Flickr

MedTech CellCentric has raised 90m in fresh funding.

The money will support the advancement of the Cambridge company's oral treatment for multiple myeloma, inobrodib.

The financing was co-led by RA Capital Management and new investor Forbion, with participation from Avego Bioscience Capital, as well as BrightEdge, the American Cancer Society's venture capital.

Read the Entire Article



Children News from...


Nike
Vermont Community Foundation
Bloomberg Philanthropies
Gates Foundation


Social Entrepreneurship
Spotlight



When it Comes to Social Enterprises, Failure is the Best Platform for Innovation


In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.




Not for Profit Jobs in Illinois

  Executive Director Jobs
  Substance Abuse Jobs
  Social Work Jobs
  Education Jobs
  Fundraising & Development Jobs